Author

Vinayak D. Bhat

Observed names: V. Bhat, V. D. Bhat, Vinayak Bhat, vinayak bhat

Institution: Elixir Medical (United States)

Observed institutions: Duke University, Duke Medical Center, Instituto Dante Pazzanese de Cardiologia, Elixir Medical (United States)

OpenAlex ID: A5111613589

A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation

2013 · Stefan Verheye, John A. Ormiston, et al. · JACC: Cardiovascular Interventions · 166

PDF

Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions

2016 · Alexandre Abizaid, Ricardo A. Costa, et al. · JACC: Cardiovascular Interventions · 110

PDF

Improving endothelial cell adhesion to vascular graft surfaces: Clinical need and strategies

1998 · Vinayak D. Bhat, Bruce Klitzman, et al. · Journal of Biomaterials Science Polymer Edition · 72

Fibronectin and avidin-biotin as a heterogeneous ligand system for enhanced endothelial cell adhesion

1998 · V. D. Bhat, G. A. Truskey, et al. · Journal of Biomedical Materials Research · 54

Using avidin-mediated binding to enhance initial endothelial cell attachment and spreading

1998 · V. D. Bhat, G. A. Truskey, et al. · Journal of Biomedical Materials Research · 48

EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions

2008 · Ribamar Costa, Alexandre Abizaid, et al. · EuroIntervention · 34

24-Month Clinical Follow-Up and Mechanistic Insights From Intravascular Imaging Following Coronary Implantation of the Novel DynamX Bioadaptor Platform

2022 · Stefan Verheye, Marie-Claude Morice, et al. · Cardiovascular revascularization medicine · 21

PDF

Elixir Medical’s bioresorbable drug eluting stent (BDES) programme: an overview

2009 · John Yan, Vinayak Bhat · EuroIntervention · 14

Fluctuating Shear Stress Effects on Stress Fiber Architecture and Energy Metabolism of Cultured Renal Cells

1995 · Vinayak D. Bhat, Paula A. Windridge, et al. · Biotechnology Progress · 10

Preclinical comparative assessment of a dedicated pediatric poly‐L‐lactic‐acid‐based bioresorbable scaffold with a low‐profile bare metal stent

2020 · Kamel Shibbani, Luiza De Lima e Silva Bagno, et al. · Catheterization and Cardiovascular Interventions · 9

TCT-563 Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

2012 · Stefan Verheye, Mark Webster, et al. · Journal of the American College of Cardiology · 9

PDF

TCT-330 Multi-Center Evaluation of a Novel 120 μm Novolimus-Eluting, Fully Bioresorbable Coronary Scaffold: First Report of 6-month Imaging and 12-Month Clinical Results

2017 · Alexandre Abizaid, Mathias Vrolix, et al. · Journal of the American College of Cardiology · 5

TCT-16 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 5-Year Clinical and Imaging Results

2017 · Stefan Verheye, Joachim Schofer, et al. · Journal of the American College of Cardiology · 4

Duraflex™ Drug-Eluting Coronary Stent System

2005 · Alexandre Abizaid, Vinayak Bhat, et al. · CRC Press eBooks · 3

CRT-4 Multi-center, First-in-man Evaluation Of The Myolimus-eluting Bioresorbable Coronary Scaffold: 6-month Clinical And Imaging Results

2013 · Stefan Verheye, Mark Webster, et al. · JACC: Cardiovascular Interventions · 1

PDF

Abstract 18819: Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

2012 · Stefan Verheye, mark webster, et al. · Circulation · 1

TCT-302 Evaluation of the Novel DESolve Myolimus-Eluting Bioresorbable Coronary Scaffold System for Treatment of De Novo Coronary Arteries: Six-Month Optical Coherence Tomography Results from the DESolve FIM Trial

2012 · Daniel Chamie, Jose Costa, et al. · Journal of the American College of Cardiology · 1

PDF

TCT-405 Drug Eluting Scaffold with an absorbable platform for primary lower extremity arterial revascularization – DESappear Study Initial Results

2017 · Andrew Holden, Kenneth Ouriel, et al. · Journal of the American College of Cardiology

PDF

Serial Angiographic Follow-up at 6 and 18 Months After Implantation of the Novel Novolimus-eluting Bioresorbable Vascular Scaffold System for the Treatment of Single De Novo Coronary Lesions: a Subanalysis of the Desolve Nx Clinical Trial

2015 · Ricardo A. Costa, Alexandre Abizaid, et al. · Journal of the American College of Cardiology

Six-month intravascular ultrasound analysis of the DESolve FIM Trial with a novel PLLA-based fully biodegradable drug-eluting Scaffold

2013 · J. Costa, S. Verheye, et al. · European Heart Journal

Serial optical coherence tomography evaluation of the novel DESolve myolimus-eluting bioresorbable vascular scaffold for the treatment of de novo coronary artery lesions

2013 · D. Chamie, A. Abizaid, et al. · European Heart Journal

Evaluation of the novel novolimus-eluting bioresorbable vascular scaffold for the treatment of de novo coronary artery stenosis: serial optical coherence tomography analysis of the DESolve NX study

2013 · D. Chamie, J. R. Costa, et al. · European Heart Journal

Works count: 22

Citation count: 562

H-index: 9

I10-index: 9